🔎 Trials Near Me

Utama › Skizofrenia › Virginia

Kajian klinikal Skizofrenia di Virginia

6 kajian untuk Skizofrenia sedang mencari peserta di lokasi di Virginia.

Bandar di Virginia

Teks kajian rasmi (Bahasa Inggeris)

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • Virginia Commonwealth University, Richmond
Mengambil pesertaFasa 3
Umur 5 hingga 17 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06229210

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • Local Institution - 0050, Richmond
Mengambil pesertaFasa 3
Umur 5 hingga 17 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07424404

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Richmond
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07105111

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

  • Local Institution - 0050, Richmond
Mengambil pesertaFasa 3
Umur 13 hingga 17 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07288567

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

  • Local Institution - 0045, Petersburg
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

  • Alkermes Investigational Site, Richmond
Mengambil pesertaFasa 3
Umur 10 hingga 17 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT05303064

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.